At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 13 enrolled
Drug / intervention
Fentanyldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label Single-Dose Crossover Study Comparing the Plasma and Cerebrospinal Fluid Pharmacokinetics and Bioavailability of Fentanyl Delivered Intranasally Versus Sublingually Versus Intravenously in Healthy Volunteers
In Brief
A Phase 4 clinical trial evaluating Fentanyl for Healthy. Completed, enrolled 13 participants.
Detailed Summary
A partially randomized, open-label, 3-way crossover, single-center, systemic and CSF PK and bioavailability study in healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartNov 2014
Primary CompletionJan 2015
Study CompletionApr 2015
First PostedJun 2015
TodayJul 2026
First PostedJun 12, 2015
Enrollment StartNov 1, 2014
Primary CompletionJan 1, 2015
Study CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.1 years ago
Interventions
Fentanyldrug
Lazanda (nasal spray), Subsys (sub-lingual) and intravenous fentanyl